Home |
Free Dividend Report |
Stock Splits Calendar |
ATHX Stock Split History |
Preferred Stock Newsletter |
ATHX Options Chain |
ATHX Message Board |

ATHX (ATHX) has 1 split in our ATHX split history database. The split for ATHX took place on August 29, 2022. This was a 1 for 25 reverse split, meaning for each 25 shares of ATHX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 40 share position following the split.
When a company such as ATHX conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ATHX split history from start to finish, an original position size of 1000 shares would have turned into 40 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ATHX shares, starting with a $10,000 purchase of ATHX, presented on a split-history-adjusted basis factoring in the complete ATHX split history.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 02/20/2015 | |
End date: | 10/20/2023 | |
Start price/share: | $59.25 | |
End price/share: | $0.02 | |
Dividends collected/share: | $0.00 | |
Total return: | -99.97% | |
Average Annual Total Return: | -60.25% | |
Starting investment: | $10,000.00 | |
Ending investment: | $3.37 | |
Years: | 8.67 |
![]() |
About ATHX |
Athersys is a biotechnology company that is focused primarily in the field of regenerative medicine. Co.'s MultiStem® (invimestrocel) cell therapy, a patented and proprietary allogeneic stem cell product, is its primary platform product and is in late-stage clinical development. By applying its proprietary MultiStem cell therapy product, Co. provides therapeutic product development programs treating neurological conditions, inflammatory and immune disorders, certain pulmonary conditions, cardiovascular disease and other conditions. Co.'s primary programs are focused in the critical care area, with treatment provided in hospitals often in intensive care situations. According to our ATHX split history records, ATHX has had 1 split. |
ATHX Split History Table | |
Date | Ratio |
08/29/2022 | 1 for 25 |
Healthcare Stock Splits |
ATHX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
ATIP Split History Also explore: ATHX shares outstanding history
|
ATHX Split History | www.SplitHistory.com | Copyright © 2013 - 2025, All Rights Reserved
Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.